EFFICACY IN CHICKENS OF A HERPESVIRUS OF TURKEYS RECOMBINANT VACCINE CONTAINING THE FUSION GENE OF NEWCASTLE-DISEASE VIRUS - ONSET OF PROTECTION AND EFFECT OF MATERNAL ANTIBODIES
Rw. Morgan et al., EFFICACY IN CHICKENS OF A HERPESVIRUS OF TURKEYS RECOMBINANT VACCINE CONTAINING THE FUSION GENE OF NEWCASTLE-DISEASE VIRUS - ONSET OF PROTECTION AND EFFECT OF MATERNAL ANTIBODIES, Avian diseases, 37(4), 1993, pp. 1032-1040
The onset of protection against Newcastle disease and the effect of ma
ternal antibodies to Newcastle disease virus (NDV) and Marek's disease
virus (MDV) on vaccine efficacy were determined following vaccination
of chickens with a recombinant herpesvirus of turkeys (HVT) vaccine e
xpressing the fusion (F) glycoprotein gene of NDV. Onset of protection
following intra-abdominal administration of the recombinant HVT/F vac
cine at 1 day of age and subsequent ocular challenge with the neurotro
pic velogenic Texas GB strain of NDV was determined to occur between d
ays 14 and 21 post-vaccination (PV). Vaccination with the Hitchner B1
strain of NDV resulted in protection by day 6 PV, and vaccination with
an inactivated NDV oil-emulsion vaccine induced protection by day 14
PV. One-day-old broiler-type chickens with maternal antibodies to both
NDV and MDV and 1-day-old specific-pathogen-free (SPF) white leghorn
chickens lacking maternal antibodies were vaccinated with the recombin
ant HVT/F vaccine or with control vaccines, challenged intra-abdominal
ly with the very virulent RB1B strain of MDV on day 8 PV, and challeng
ed with the Texas GB strain of NDV on day 29 PV. The HVT/F and NDV str
ain Hitchner B1 vaccines provided 73% and 80% protection, respectively
, against NDV in broilers, whereas both vaccines resulted in 100% prot
ection in SPF leghorns.